tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
Want to see GMAB full AI Analyst Report?

Genmab (GMAB) Blogger Opinions & Sentiment

776 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
GMAB Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
80% SeekingAlpha
20% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Genmab: Multiple Binaries Could Alter The Thesis
SeekingAlpha
Genmab (GMAB) Receives Buy Rating from Jefferies with Positive Outlook
GuruFocus
Genmab Transitioning To A Global Oncology Powerhouse: Why I Choose To Buy
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of GMAB?
Seeking Alpha’s Biologics has a Bullish Sentiment.
    What do Motley Fool contributors think of GMAB?
    Currently there's no blogger sentiment for GMAB.
    What Is GMAB’s Blogger Sentiment?
    GMAB’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for GMAB?
      The most recent blogger prediction for GMAB was made by Biologics, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited